RO 443888

Drug Profile

RO 443888

Latest Information Update: 20 Jul 2000

Price : $50

At a glance

  • Originator Genentech; Roche
  • Class Small molecules
  • Mechanism of Action GPIIb-IIIa antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arterial thrombosis

Most Recent Events

  • 20 Jul 2000 Investigation in Arterial thrombosis in USA (Unknown route)
  • 20 Jul 2000 Investigation in Arterial thrombosis in Switzerland (Unknown route)
  • 24 Mar 1998 A clinical study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top